Fifth Third Bancorp
IMVT icon

Fifth Third Bancorp’s Immunovant IMVT Stock Holding History

Fifth Third Bancorp’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Hold
319
– – ﹤0.01% 3689
2026
Q1 		$7.92K Buy
+319
New +$8.26K ﹤0.01% 3755
2020
Q4 		– Sell
-5,587
Closed -$197K – 2400
2020
Q3 		$197K Hold
5,587
– – ﹤0.01% 878
2020
Q2 		$136K Buy
+5,587
New +$120K ﹤0.01% 995

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fifth Third Bancorp's IMVT Position: Q2 2026 in Review

Fifth Third Bancorp held its Immunovant (IMVT) position steady in Q2 2026 at 319 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3689.

Fifth Third Bancorp first reported a position in IMVT in Q2 2020 and has held it in 4 quarters since. The position peaked at $197K in Q3 2020. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Fifth Third Bancorp held 319 shares of Immunovant worth $12.3K as of Q2 2026.
  • Fifth Third Bancorp left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3689 holding.
  • Fifth Third Bancorp first reported a position in Immunovant in Q2 2020 and has held it in 4 quarters since.
  • Fifth Third Bancorp's Immunovant position peaked at $197K in Q3 2020.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.